Back
Maze Therapeutics Stock Price Chart

5 Stocks to Consider Immediately (must-see chart)
See the green days for 5 major stocks right here, free of charge
Sell
33
MAZE
Maze Therapeutics
Last Price:
$11.86
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
The current trend is moderately bearish and MAZE is experiencing slight selling pressure.
Maze Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.74 | Sell |
20-day SMA: | 12.22 | Sell |
50-day SMA: | 10.98 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 11.8 | Sell |
20-day EMA: | 11.83 | Sell |
50-day EMA: | 10.44 | Buy |
200-day EMA: | 5.01 | Buy |
Maze Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 48.41 | Sell |
Chaikin Money Flow: | -22484 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.22 - 13.28) | Sell |
Bollinger Bands (100): | (9.33 - 12.47) | Buy |
Maze Therapeutics Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Maze Therapeutics Stock
Is Maze Therapeutics Stock a Buy?
-
Maze Therapeutics share price is 11.50 while MAZE 8-day simple moving average is 11.74, which is a Sell signal.
-
The stock price of MAZE is 11.50 while Maze Therapeutics 20-day SMA is 12.22, which makes it a Sell.
-
Maze Therapeutics 50-day simple moving average is 10.98 while MAZE share price is 11.50, making it a Buy technically.
-
MAZE stock price is 11.50 and Maze Therapeutics 200-day simple moving average is 0.00, creating a Buy signal.
MAZE Technical Analysis vs Fundamental Analysis
Sell
33
Maze Therapeutics (MAZE)
is a Sell
Is Maze Therapeutics a Buy or a Sell?
-
Maze Therapeutics stock is rated a SellThe current Maze Therapeutics [MAZE] share price is $11.50. The Score for MAZE is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Maze Therapeutics Stock Info
Market Cap:
492.5M
Price in USD:
11.50
Share Volume:
78.2K
Maze Therapeutics 52-Week Range
52-Week High:
17.00
52-Week Low:
6.71
Sell
33
Maze Therapeutics (MAZE)
is a Sell
Maze Therapeutics Share Price Forecast
-
What is the Maze Therapeutics stock price today?The Maze Therapeutics stock price is 11.50 USD today.
-
Will MAZE stock go up or go down?Maze Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Maze Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Maze Therapeutics is overvalued.
Is Maze Therapeutics Stock a Buy?
-
Maze Therapeutics share price is 11.50 while MAZE 8-day exponential moving average is 11.80, which is a Sell signal.
-
The stock price of MAZE is 11.50 while Maze Therapeutics 20-day EMA is 11.83, which makes it a Sell.
-
Maze Therapeutics 50-day exponential moving average is 10.44 while MAZE share price is 11.50, making it a Buy technically.
-
MAZE stock price is 11.50 and Maze Therapeutics 200-day simple moving average is 5.01, creating a Buy signal.
Fundamental Analysis of Maze Therapeutics
Is Maze Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.07 per share, an increase this year of $16.03 per share, and an increase next year of $0.67 per share.
Technical Analysis of Maze Therapeutics
Should I short Maze Therapeutics stock?
-
MAZE Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Maze Therapeutics is a Buy
-
Maze Therapeutics Relative Strength Index (RSI) is 48.41, which suggest Maze Therapeutics is oversold
-
The Bollinger Bands (25) for Maze Therapeutics is (11.22 - 13.28), which suggest Maze Therapeutics is a Buy
-
The Bollinger Bands (100) for Maze Therapeutics is (9.33 - 12.47), which suggest Maze Therapeutics is a Buy
* Maze Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.